Ilumivu
Fairview, US · Founded 2021 · Delaware corporation · 1 known investors
ilumivu builds software platforms for behavioral and clinical research, including tools for running clinical trials, patient engagement, and multisite collaborative research using wearable and mobile technology. The company originated in support of families of children with autism and works with researchers, clinicians, and healthcare organizations.
AI & Machine LearningDigital HealthHealthtechMental HealthSaaS
Founders & leadership
SG
Sandeep GoelNamed on SEC filing
K
Kat
MT
Mark TuomenoksainCo-Founder & Chief Technology OfficerHe founded OpenReach in 1999 and led it as CEO until its merger into Oracle in 2003, and has owned and run Tefsoft Inc since 2003. His earlier work includes consulting for CTC Communications and One Communications, a board seat at Network-1 Security Solutions, and a software engineering and marketing role at Angel Medical Systems.
LP
Lauren Pierce FlickingerinChief Executive Officer
KR
Kate RahimzadehChief Operating Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements$256.2K disclosed across 1 of 4 rounds · 2021–2023
▶$256.2KraisedNov 2023 · 2 investors · Other TechnologyRule 506(b)
▶$256.2KraisedNov 2023 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Eric ReifsniderExecutive Officer
- James Bradley WilsonDirector
- Kevin McCarthyDirector
- Marc Frank JacksonDirector
- Sandeep GoelExecutive Officer, Director, Promoter
- Daniel RossDirector
- Susan SteinmanExecutive Officer
- Michael HelmekeExecutive Officer
- Lauren Pierce FlickingerDirector
- Offering amount
- $1.5M
- Amount sold
- $256.2K
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$1.5MofferedJan 2023 · Other TechnologyRule 506(b)
▶$1.5MofferedJan 2023 · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Sandeep GoelExecutive Officer, Director, Promoter
- Kevin McCarthyDirector
- Thomas David SmithExecutive Officer, Director, Promoter
- Lauren Pierce FlickingerDirector
- Dan RossDirector
- Offering amount
- $1.5M
- Proceeds to insiders
- $150K
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$2.5MofferedApr 2022 · Other TechnologyRule 506(b)
▶$2.5MofferedApr 2022 · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Dan RossDirector
- Thomas David SmithExecutive Officer, Director, Promoter
- Kevin McCarthyDirector
- Sandeep GoelExecutive Officer, Director, Promoter
- Offering amount
- $2.5M
- Minimum investment
- $100K
- Proceeds to insiders
- $150K
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$10.6MofferedOct 2021 · Other TechnologyRule 506(b)
▶$10.6MofferedOct 2021 · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Sandeep GoelExecutive Officer, Director, Promoter
- Offering amount
- $10.6M
- Minimum investment
- $10K
- Proceeds to insiders
- $150K
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapExpiWell17 shared keywordsExpiWell offers a no-code platform and native iOS/Android apps for Ecological Momentary Assessment (EMA/ESM), letting researchers collect real-time survey, wearable, sensor, and geofenced data in participants' natural environments. It serves academic and clinical researchers running longitudinal and field studies, with HIPAA/GDPR compliance and real-time analytics dashboards.
Oup9 shared keywordsOxford University Press publishes research, educational, and reference materials, including reports on reading and children's learning, and reference resources such as its dictionary "Word of the Day." It serves readers, educators, and learners across a wide range of subjects worldwide.
Companies competing with Ilumivu for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Ilumivu do?
- ilumivu builds software platforms for behavioral and clinical research, including tools for running clinical trials, patient engagement, and multisite collaborative research using wearable and mobile technology. The company originated in support of families of children with autism and works with researchers, clinicians, and healthcare organizations.
- Who are Ilumivu's investors?
- Ilumivu's investors include Hatteras Venture Partners.
- How much funding has Ilumivu raised?
- Ilumivu has disclosed $256.2K raised across 1 of its 4 known rounds.
- Where is Ilumivu headquartered?
- Ilumivu is headquartered in Fairview, US.